KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Work In Process (2017 - 2025)

ClearPoint Neuro's Work In Process history spans 13 years, with the latest figure at $5.7 million for Q1 2025.

  • On a quarterly basis, Work In Process changed N/A to $5.7 million in Q1 2025 year-over-year; TTM through Mar 2025 was $5.7 million, a N/A change, with the full-year FY2024 number at $5.5 million, down 14.89% from a year prior.
  • Work In Process hit $5.7 million in Q1 2025 for ClearPoint Neuro, up from $5.5 million in the prior quarter.
  • Over the last five years, Work In Process for CLPT hit a ceiling of $6.5 million in Q4 2023 and a floor of $1.6 million in Q1 2021.
  • Historically, Work In Process has averaged $3.9 million across 4 years, with a median of $3.9 million in 2021.
  • Biggest five-year swings in Work In Process: skyrocketed 34.21% in 2021 and later fell 14.89% in 2024.
  • Tracing CLPT's Work In Process over 4 years: stood at $2.3 million in 2021, then soared by 179.43% to $6.5 million in 2023, then fell by 14.89% to $5.5 million in 2024, then rose by 2.73% to $5.7 million in 2025.
  • Business Quant data shows Work In Process for CLPT at $5.7 million in Q1 2025, $5.5 million in Q4 2024, and $6.5 million in Q4 2023.